Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

HIV Infection

Free Subscription 08.07.2024 5 AIDS 4 AIDS Res Hum Retroviruses 1 Am J Epidemiol 2 Antimicrob Agents Chemother 1 Blood 1 BMC Cancer 1 BMC Neurol 1 BMC Pediatr 4 Clin Infect Dis 1 Drugs 1 HIV Med 1 Int J Dermatol 1 J Clin Invest 1 J Med Virol 1 PLoS Biol 11 PLoS One 1 Proc Natl Acad Sci U S A 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. BAMFORD L, Rajagopal A, Grelotti D, Justice-Royster V, et al
   Impact of methamphetamine use on HIV and other health outcomes at an urban HIV medicine clinic.
   AIDS. 2024 Jul 3. doi: 10.1097/QAD.0000000000003975.
   PubMed         Abstract available
   
   
2. WILLIAMS LD, van Heerden A, Friedman SR, Chibi B, et al
   Comparison of a novel expanded social network recruitment intervention with risk network recruitment to HIV testing: locating undiagnosed cases in South Africa.
   AIDS. 2024 Jul 3. doi: 10.1097/QAD.0000000000003976.
   PubMed         Abstract available
   
   
3. SILHOL R, Maheu-Giroux M, Soni N, Fotso AS, et al
   The impact of past HIV interventions and diagnosis gaps on new HIV acquisitions, transmissions, and HIV-related deaths in Cote d'Ivoire, Mali, and Senegal.
   AIDS. 2024 Jul 2. doi: 10.1097/QAD.0000000000003974.
   PubMed         Abstract available
   
   
4. KING EM, Tkachuk S, Tseng A
   Aging on Antiretrovirals: Reviewing the need for pharmacologic data in elderly people living with HIV.
   AIDS. 2024 Jul 2. doi: 10.1097/QAD.0000000000003973.
   PubMed        
   
   
5. GRAM EJPN, Moseholm E, Norlov AB, Wilken-Jensen C, et al
   Cervical cancer screening integrated in routine clinical care of women living with HIV.
   AIDS. 2024 Jun 28. doi: 10.1097/QAD.0000000000003972.
   PubMed         Abstract available
   
   

   
   AIDS Res Hum Retroviruses

6. WANG Y, Yang C, Jin X, Chen H, et al
   HIV-1 molecular networks and pretreatment drug resistance at the frontier of Yunnan Province, China.
   AIDS Res Hum Retroviruses. 2024 Jul 3. doi: 10.1089/AID.2023.0124.
   PubMed         Abstract available
   
   
7. BBOSA N, Holzmayer V, Ssemwanga D, Downing R, et al
   Near full-length genome analysis of the first-reported HIV-1 Circulating Recombinant Form (CRF)_10CD in Uganda.
   AIDS Res Hum Retroviruses. 2024 Jul 3. doi: 10.1089/AID.2024.0034.
   PubMed         Abstract available
   
   
8. BYRNE M, Resnik J, Horberg M, Greenberg AE, et al
   Factors associated with time to initial antiretroviral regimen discontinuation in the DC Cohort.
   AIDS Res Hum Retroviruses. 2024 Jul 3. doi: 10.1089/AID.2024.0002.
   PubMed         Abstract available
   
   
9. HASER GC, Balter LB, Gurley SA, Thomas M, et al
   Early Implementation and Outcomes Among People with HIV who Accessed Long Acting Injectable-Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. South.
   AIDS Res Hum Retroviruses. 2024 Jul 3. doi: 10.1089/AID.2024.0007.
   PubMed         Abstract available
   
   

   
   Am J Epidemiol

10. CANIGLIA EC, Zash R, Diseko M, Mayondi G, et al
    How much could anemia-related interventions reduce the HIV disparity in adverse birth outcomes?
    Am J Epidemiol. 2024 Jul 4:kwae160. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Antimicrob Agents Chemother

11. VAN GULCK E, Pardons M, Nijs E, Verheyen N, et al
    Correction for Van Gulck et al., "A truncated HIV Tat demonstrates potent and specific latency reversal activity".
    Antimicrob Agents Chemother. 2024 Jul 2:e0081924. doi: 10.1128/aac.00819.
    PubMed        
    
    
12. MATTHEWS RP, Liu Y, Matthews C, Butterfield KL, et al
    Thorough QT/QTc study to evaluate the effect of a single supratherapeutic dose of islatravir on QTc interval prolongation in healthy adults.
    Antimicrob Agents Chemother. 2024 Jul 2:e0046424. doi: 10.1128/aac.00464.
    PubMed         Abstract available
    
    

    
    Blood

13. LUCENA LAGE S, Ramaswami R, Rocco J, Rupert A, et al
    Inflammasome activation in patients with Kaposi sarcoma herpesvirus (KSHV)-associated disorders.
    Blood. 2024 Jun 28:blood.2024024144. doi: 10.1182/blood.2024024144.
    PubMed         Abstract available
    
    

    
    BMC Cancer

14. MBAI MM, Mduma E, Thuo S, Rugengamanzi E, et al
    A comparison of clinical profile and treatment outcome of Hodgkin's Lymphoma in Tanzania according to HIV status during the HAART era.
    BMC Cancer. 2024;24:796.
    PubMed         Abstract available
    
    

    
    BMC Neurol

15. DAMBIETZ C, Heming M, Brix TJ, Schulte-Mecklenbeck A, et al
    Severe CSF immune cell alterations in cryptococcal meningitis gradually resolve during antifungal therapy.
    BMC Neurol. 2024;24:229.
    PubMed         Abstract available
    
    

    
    BMC Pediatr

16. HELLEN N, Joseph R, Ezekiel M, Fred S, et al
    Proportion of HIV exposed infants aged 0-6 months that missed nevirapine prophylaxis in Mulago National Referral Hospital, Uganda: a cross-sectional study.
    BMC Pediatr. 2024;24:430.
    PubMed         Abstract available
    
    

    
    Clin Infect Dis

17. COLLINS LF, Sheth AN, Tisdale T, Mehta CC, et al
    Interest in and Preference for Long-acting Injectable Antiretroviral Therapy in the Era of Approved Cabotegravir/Rilpivirine among Reproductive-aged Women in the U.S. South.
    Clin Infect Dis. 2024 Jun 29:ciae331. doi: 10.1093.
    PubMed         Abstract available
    
    
18. KIMUDA S, Kwizera R, Dai B, Kigozi E, et al
    Comparison of early fungicidal activity and mortality between daily liposomal amphotericin B and daily amphotericin B deoxycholate among patients with HIV-associated cryptococcal meningitis.
    Clin Infect Dis. 2024 Jun 29:ciae326. doi: 10.1093.
    PubMed         Abstract available
    
    
19. MOHAREB AM, Barshak MB, Papaliodis GN, Sobrin L, et al
    Ocular syphilis in patients with nonreactive RPR and positive treponemal serologies: a retrospective observational cohort study.
    Clin Infect Dis. 2024 Jul 2:ciae354. doi: 10.1093.
    PubMed         Abstract available
    
    
20. GUTIERREZ F, Lopez L, Galera C, Tiraboschi JM, et al
    Early Detection of Cancer and Precancerous Lesions in Persons with HIV through a Comprehensive Cancer Screening Protocol.
    Clin Infect Dis. 2024 Jul 3:ciae359. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Drugs

21. KEAM SJ
    Nogapendekin alfa Inbakicept: First Approval.
    Drugs. 2024 Jul 5. doi: 10.1007/s40265-024-02060.
    PubMed         Abstract available
    
    

    
    HIV Med

22. VERMA A, Pant M, Khatib MN, Singh MP, et al
    Commentary on 'Impact of hormonal therapy on HIV-1 immune markers in cis women and gender minorities'.
    HIV Med. 2024 Jul 2. doi: 10.1111/hiv.13687.
    PubMed        
    
    

    
    Int J Dermatol

23. MCKENZIE NC, Hickey MD, De la Sancha C, Coates SJ, et al
    Ulcerative erythematous papules and plaques on the face and lower legs of a man living with HIV: a clinicopathological challenge.
    Int J Dermatol. 2024 Jul 4. doi: 10.1111/ijd.17362.
    PubMed         Abstract available
    
    

    
    J Clin Invest

24. KLOTMAN ME, Haynes BF
    The other pandemic: lessons from 40 years of HIV research.
    J Clin Invest. 2024;134:e183039.
    PubMed        
    
    

    
    J Med Virol

25. MCCLURE CP, Kean K, Reid K, Mayne R, et al
    Reconstruction of the historic time course of blood-borne virus contamination of clotting factor concentrates, 1974-1992.
    J Med Virol. 2024;96:e29774.
    PubMed         Abstract available
    
    

    
    PLoS Biol

26. LEGRAND A, Dahoui C, De La Myre Mory C, Noy K, et al
    SAMD9L acts as an antiviral factor against HIV-1 and primate lentiviruses by restricting viral and cellular translation.
    PLoS Biol. 2024;22:e3002696.
    PubMed         Abstract available
    
    

    
    PLoS One

27. SIAW ADJ, Amugsi J, Owusu-Konadu MAA, Drah ST, et al
    Prevalence and risk factors of Hepatitis C virus infection in the Upper East Region of Ghana; a community-based cross-sectional study.
    PLoS One. 2024;19:e0306292.
    PubMed         Abstract available
    
    
28. SAAKA SA, Antabe R
    Endorsement of HIV-related stigma among men in Ghana: What are the determinants?
    PLoS One. 2024;19:e0305811.
    PubMed         Abstract available
    
    
29. LEE KH, Jiamsakul A, Kiertiburanakul S, Borse R, et al
    Risk factors for toxoplasmosis in people living with HIV in the Asia-Pacific region.
    PLoS One. 2024;19:e0306245.
    PubMed         Abstract available
    
    
30. SHANLEY A, O'Donnell K, Weatherburn P, Gilmore J, et al
    Understanding sexual health service access for gay, bisexual and other men who have sex with men in Ireland during the COVID-19 crisis: Findings from the EMERGE survey.
    PLoS One. 2024;19:e0306280.
    PubMed         Abstract available
    
    
31. MALAMBO W, Chanda D, Besa L, Engamba D, et al
    Clinical characteristics and factors associated with long COVID among post-acute COVID-19 clinic patients in Zambia, August 2020 to January 2023: A cross-sectional and longitudinal study design.
    PLoS One. 2024;19:e0306131.
    PubMed         Abstract available
    
    
32. BASIMANE BISIMWA P, Koyaweda GW, Bihehe Masemo D, Ayagirwe RBB, et al
    High prevalence of hepatitis B and HIV among women survivors of sexual violence in South Kivu province, eastern Democratic Republic of Congo.
    PLoS One. 2024;19:e0292473.
    PubMed         Abstract available
    
    
33. BAN KF, Rogers E, Khan M, Scheidell J, et al
    Does smoking cessation reduce other substance use, psychiatric symptoms, and pain symptoms? Results from an emulated hypothetical randomized trial of US veterans.
    PLoS One. 2024;19:e0298576.
    PubMed         Abstract available
    
    
34. TONGTOYAI J, Cherdtrakulkiat T, Girdthep N, Masciotra S, et al
    Data quality assessment of the Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), Thailand, 2015-2021.
    PLoS One. 2024;19:e0305296.
    PubMed         Abstract available
    
    
35. PEDROSA NL, Pinheiro PM, Filho FWBH, de Araujo WN, et al
    Incidence and risk factors associated with acquired syphilis in HIV pre-exposure prophylaxis users.
    PLoS One. 2024;19:e0303320.
    PubMed         Abstract available
    
    
36. GOBIR IB, Agboola S, Nnadozie HO, Adamu H, et al
    Patients and healthcare workers' preferences for using smart lockers in accessing and dispensing chronic disease medication in Nigeria: Findings from a descriptive cross-sectional study.
    PLoS One. 2024;19:e0303625.
    PubMed         Abstract available
    
    
37. KASSAW A, Asferie WN, Azmeraw M, Kefale D, et al
    Incidence and predictors of tuberculosis among HIV-infected children after initiation of antiretroviral therapy in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0306651.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

38. PURCELL H, Kohler IV, Ciancio A, Mwera J, et al
    Mortality risk information and health-seeking behavior during an epidemic.
    Proc Natl Acad Sci U S A. 2024;121:e2315677121.
    PubMed         Abstract available
    
    

    
    Virology

39. KIM J, Villar Z, Jobe O, Rerks-Ngarm S, et al
    Broadly neutralizing antibodies and monoclonal V2 antibodies derived from RV305 inhibit capture and replication of HIV-1.
    Virology. 2024;597:110158.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.